InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 06/13/2019 3:19:04 PM

Thursday, June 13, 2019 3:19:04 PM

Post# of 768
From Jefferies: ''CEO Maria Fardis proposed the best scenario of FDA discussion would be full conversion of existing pts to a pivotal cohort where the co would enroll btwn 75-100 patients. By our estimate, IOVA could finish enrolling by YE '19 and file in '20. If FDA requires a new pivotal cohort, it could finish enrollment by 1H’20 and file by YE' 20/early '21. We think this cervical regulatory update in mid '19 is the next catalyst for shares.''
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News